Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a neurological disorder characterized by progressive weakness and impaired sensory function due to damage to the myelin sheath that insulates nerve fibers. It is believed to be an autoimmune condition, where the body's immune system mistakenly attacks the peripheral nerves. Symptoms often include muscle weakness, numbness, and fatigue, and they can vary in severity. Treatment typically involves immunotherapy, such as corticosteroids or intravenous immunoglobulin (IVIG), to reduce inflammation and improve nerve function.
i have ms and cidp. i am looking for other people who use hydrocodone or norco or vicodin
IgG therapy is thought to help CIDP (chronic inflammatory demyelinating polyneuropathy) by reducing inflammation in the peripheral nerves and modifying the immune response. It can help to stabilize the condition and improve nerve function in some patients with CIDP.
The ICD-9 code for Guillain-Barré Syndrome is 357.0. This code falls under the category of inflammatory and demyelinating diseases of the nervous system. It specifically refers to acute inflammatory demyelinating polyneuropathy, which is the most common form of Guillain-Barré Syndrome.
Chronic inflammatory demyelinating polyneuropathy (CIDP) can affect individuals of any age, but it's more commonly diagnosed in adults, with a peak incidence between 40-60 years old. Both men and women are affected, although CIDP is slightly more prevalent in men. There is no specific racial or ethnic predilection for CIDP.
not in l.a. but one in palm springs
Yes, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is classified as an autoimmune disease. In CIDP, the immune system mistakenly attacks the peripheral nerves, leading to inflammation and damage to the myelin sheath that insulates these nerves. This results in symptoms such as weakness, numbness, and impaired motor function. Treatment often involves therapies aimed at modulating the immune response.
Yes, sensory demyelinating polyneuropathy primarily affects the sensory nerve fibers by damaging the myelin sheath that surrounds them. This results in impaired transmission of sensory signals from the peripheral nerves to the central nervous system, leading to symptoms such as numbness, tingling, and reduced sensation.
Yes. Perry was hospitalized in April, 2009 for Chronic Inflammatory Demyelinating Polyneuropathy, a disease that affects the nervous system and is a result of being afflicted with Guillain-Barre Syndrome, a disease where the immune system attacks the nerves causing weakness and numbness in the arms and legs. Perry was hospitalized for about 5 weeks and left the hospital to receive rehabilation at an undisclosed location.
Prolonged inflammation, healing of the tissue from the inflammatory process
polymyositis
idiopathic inflammatory demyelinating diseases Vitamin B12 deficiency Central pontine myelinolysis Tabes Dorsalis transverse myelitis Devic's disease progressive multifocal leukoencephalopathy Optic neuritis Leukodystrophies A demyelinating disease is any disease of the nervous system in which the myelin sheath of neurons is damaged. Demyelinating describes the effect of the disease, rather than its cause; some demyelinating diseases are caused by genetics, some by infectious agents, some by autoimmune reactions, and some by unknown factors.
A demyelinating disease is any disease of the nervous system.